Bioavailability is measured by what?

Bioavailability is measured by what?

• A. Measured by the amount of drug in the plasma.
• B. The rate and extent to which the active ingredient is absorbed and becomes available at the intended site of drug action.
• C. The time to peak concentration after dosing.
• D. The maximum concentration achieved in plasma.

Answer: (A)

Bioavailability is about how much of the administered drug actually becomes available to have an effect at the site of action, and how quickly that happens. In other words, it reflects both the extent of absorption (how much enters systemic circulation) and the rate at which it is absorbed so that the active ingredient can reach its site of action in a useful amount and at the right time. The description that captures this full idea states that bioavailability is the rate and extent to which the active ingredient is absorbed and becomes available at the intended site of drug action. Relying only on the amount of drug found in plasma describes exposure, which is related but not the complete definition of bioavailability. It’s a useful proxy for comparison, but it doesn’t by itself specify the site-of-action availability or the absorption rate. The maximum plasma concentration and the time to peak describe specific aspects of absorption timing, not the overall fraction that ultimately becomes available at the action site.

Bioavailability is about how much of the administered drug actually becomes available to have an effect at the site of action, and how quickly that happens. In other words, it reflects both the extent of absorption (how much enters systemic circulation) and the rate at which it is absorbed so that the active ingredient can reach its site of action in a useful amount and at the right time. The description that captures this full idea states that bioavailability is the rate and extent to which the active ingredient is absorbed and becomes available at the intended site of drug action.

Relying only on the amount of drug found in plasma describes exposure, which is related but not the complete definition of bioavailability. It’s a useful proxy for comparison, but it doesn’t by itself specify the site-of-action availability or the absorption rate. The maximum plasma concentration and the time to peak describe specific aspects of absorption timing, not the overall fraction that ultimately becomes available at the action site.